Skip to content 
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong. more
| Time Frame | HKPD | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | -10.89% | 1.33% | 0.74% |
| 1-Month Return | -12.68% | 7.04% | 1.28% |
| 3-Month Return | -41.37% | 16.42% | 3.6% |
| 6-Month Return | -33.55% | 15.64% | 7.31% |
| 1-Year Return | -64.94% | 26.14% | 11.97% |
| 3-Year Return | -75.26% | 73.88% | 72.07% |
| Mar '23 | Mar '24 | Mar '25 | ||||
|---|---|---|---|---|---|---|
| Total Revenue | 12.56M | 16.69M | 20.31M | [{"date":"2023-03-31","value":61.81,"profit":true},{"date":"2024-03-31","value":82.15,"profit":true},{"date":"2025-03-31","value":100,"profit":true}] | ||
| Cost of Revenue | 9.82M | 13.13M | 17.90M | [{"date":"2023-03-31","value":54.85,"profit":true},{"date":"2024-03-31","value":73.36,"profit":true},{"date":"2025-03-31","value":100,"profit":true}] | ||
| Gross Profit | 2.74M | 3.56M | 2.42M | [{"date":"2023-03-31","value":76.96,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":67.87,"profit":true}] | ||
| Gross Margin | 21.81% | 21.32% | 11.89% | [{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":97.76,"profit":true},{"date":"2025-03-31","value":54.5,"profit":true}] | ||
| Operating Expenses | 1.70M | 1.95M | 2.28M | [{"date":"2023-03-31","value":74.25,"profit":true},{"date":"2024-03-31","value":85.43,"profit":true},{"date":"2025-03-31","value":100,"profit":true}] | ||
| Operating Income | 1.04M | 1.61M | 132.04K | [{"date":"2023-03-31","value":64.9,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":8.21,"profit":true}] | ||
| Total Non-Operating Income/Expense | (46.05K) | (164.58K) | (191.85K) | [{"date":"2023-03-31","value":-4604600,"profit":false},{"date":"2024-03-31","value":-16458400,"profit":false},{"date":"2025-03-31","value":-19185200,"profit":false}] | ||
| Pre-Tax Income | 1.02M | 1.53M | 36.11K | [{"date":"2023-03-31","value":66.89,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":2.37,"profit":true}] | ||
| Income Taxes | 22.57K | 196.25K | 63.17K | [{"date":"2023-03-31","value":11.5,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":32.19,"profit":true}] | ||
| Income After Taxes | 998.20K | 1.33M | (27.06K) | [{"date":"2023-03-31","value":75.07,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-2.03,"profit":false}] | ||
| Income From Continuous Operations | 998.20K | 1.33M | (27.06K) | [{"date":"2023-03-31","value":75.07,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-2.03,"profit":false}] | ||
| Income From Discontinued Operations | - | - | - | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}] | ||
| Net Income | 998.20K | 1.33M | (27.06K) | [{"date":"2023-03-31","value":75.07,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-2.03,"profit":false}] | ||
| EPS (Diluted) | - | - | - | [{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}] | ||
These ratios help you determine the liquidity of the company. Higher is better.
| HKPD | |
|---|---|
| Cash Ratio | 1.03 |
| Current Ratio | 2.99 |
| Quick Ratio | 2.80 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| HKPD | |
|---|---|
| ROA (LTM) | 1.32% |
| ROE (LTM) | -0.59% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| HKPD | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.47 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.53 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| HKPD | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 0.38 |
| P/B | 1.76 |
| Price/FCF | NM |
| EV/R | 0.40 |
| EV/Ebitda | 6.76 |
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) share price today is $0.6977
Yes, Indians can buy shares of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) on Vested. To buy
Yes, you can purchase fractional shares of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) via the Vested app. You can start investing in Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) with a minimum investment of $1.
You can invest in shares of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) via Vested in three simple steps:
The 52-week high price of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) is $2.76. The 52-week low price of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) is $0.66.
The price-to-earnings (P/E) ratio of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) is
The price-to-book (P/B) ratio of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) is 1.76
The dividend yield of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) is 0.00%
The market capitalization of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) is $7.73M
The stock symbol (or ticker) of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares is HKPD
Consider the share price of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
